EditorialEditorial
Open Access

Inflammatory signaling in targeted therapy resistance: focus on EGFR-targeted treatment

Zhihong Luo and Ke Gong
Cancer Biology & Medicine October 2024, 21 (10) 831-837; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0327

Article Information

vol. 21 no. 10 831-837
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2024.0327
PubMed 
39475221
Published By 
Cancer Biology & Medicine
History 
  • Received August 29, 2024
  • Accepted September 25, 2024
  • Published online October 30, 2024.
Copyright & Usage 
Copyright: © 2024 The Authors This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License.

Author Information

Funding

  • National Natural Science Foundation of China

    82372854

  • Excellent Young Scholars, the Fundamental Research Funds for the Central Universities, and the National Science Foundation of Hubei Province

    2022CFA008

This study was supported by the National Natural Science Foundation of China (Grant No. 82372854) and for Excellent Young Scholars, the Fundamental Research Funds for the Central Universities, and the National Science Foundation of Hubei Province (Grant No. 2022CFA008).

Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section